DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Sodium stibogluconate
Sodium stibogluconate
Review Article Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions
Drugs for Amebiais, Giardiasis, Trichomoniasis & Leishmaniasis
204684Orig1s000
Guidelines for Diagnosis, Treatment and Prevention of Visceral Leishmaniasis in South Sudan
Public Health Goal for ANTIMONY in Drinking Water
204684Orig1s000
Tapeworm Infection1.Qxd
The Selection and Use of Essential Medicines
The Medical Letter
Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: a Systematic Review
Comparative Efficacy of Intra-Lesional Sodium Stibogluconate
Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
Perspectives of Antimony Compounds in Oncology
Drugs for Parasitic Infections (2013 Edition)
Antiprotozoal Compounds: State of the Art and New Developments F
Sodium Stibogluconate: Therapeutic Use in the Management of Leishmaniasis
Randomized Double Blind Study on Efficacy of Intralesional
National Licensed Medicine List of Afghanistan
Top View
Interactions Pharmacokinetics Uses and Administration Adverse Effects
ECG Changes in Patients of Visceral Leishmaniasis (Kala-Azar) Receiving Sodium Stibogluconate Therapy
Microbiome Manipulation: Antibiotic Effects on Cutaneous Leishmaniasis Presentation and Healing
PROVISIONAL PEER REVIEWED TOXICITY VALUES for SOLUBLE ANTIMONY COMPOUNDS (VARIOUS Casrns)
In Vitro and in Vivo Activity of Meglumine Antimoniate Produced at Farmanguinhos-Fiocruz, Brazil, Against Leishmania (Leishmania
Leishmaniasis in the Americas. Treatment Recommendations
Enterobius Vermicularis Infection1.Qxd
Manual for Case Management of Cutaneous Leishmaniasis in the WHO Eastern Mediterranean Region
Costs of Medicines in Current Use for the Treatment of Leishmaniasis
Control of Leishmaniasis
Comparison Between the Efficacy and Safety of Intralesional Sodium
Successful Treatment with Intralesional Meglumine Antimoniate in Recurrent Cutaneous Leishmaniasis: Case Report
The Medical Letter
National Essential Medicine List of Afghanistan
1 Supplementary Appendix Table of Contents Appendix
Antimony Toxicity
Summary of Product Characteristics 1 Name Of
WHO Model List of Essential Medicines
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
7Th Invitation to Manufacturers of Medicinal Products for the Treatment
Cross Discipline Team Leader Review
Antimony in Drinking-Water
Metronidazole and Indian Kala-Azar: Metronidazole and to Mr Amar Nath Jha for Typing and Retyping the Manuscript
In 2003, the MOPH Published a First National Essential Drug List (EDL)
204684Orig1s000
Facts & Figures
Safety and Effectiveness of Meglumine Antimoniate in the Treatment of Ethiopian Visceral Leishmaniasis Patients with and Without HIV Co-Infection
Infoleishth Redeleish Newsletter-4 Edition July 2019
ATC Code Title
In Vitro Susceptibility of Trypanosoma Cruzi Strains from Santander, Colombia, to Hexadecylphosphocholine
Comparison of Generic and Proprietary Sodium Stibogluconate
At Sublethal Doses of Gammacyhalothrin
CHAPTER E26 Pharmacology of Agents Used to Treat Parasitic Infections
In Vitro and in Vivo Interactions Between Miltefosine and Other Antileishmanial Drugs Karin Seifert and Simon L
Zoonotic & Parasitic Treatment Guidance
The Selection and Use of Essential Medicines